Molecular epidemiology of drug resistance markers of Plasmodium falciparum in Yunnan Province, China

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Huang, Fang ^a   Tang, Linhua ^a   Yang, Henglin ^b   Zhou, Shuisen ^a   Liu, Hui ^b   Li, Junwei ^a   Guo, Shaohua ^a  

^a BEIJING HOSPITAL   (China)

^b Yunnan Institute of Parasitic Diseases   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ARTEMISININ; CHLOROQUINE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; PYRIMETHAMINE PLUS SULFADOXINE;

ALLELE; ARTICLE; BLOOD SAMPLING; CHINA; CODON; DRUG SURVEILLANCE PROGRAM; GENE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MOLECULAR EPIDEMIOLOGY; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SUBSTITUTION; BLOOD; CHINA; DNA, PROTOZOAN; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; MOLECULAR EPIDEMIOLOGY; MUTATION, MISSENSE; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTOZOAN PROTEINS;

EID: 84864194498     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-243     Document Type: Article

References (52)

1. Malaria Disease Burden in SEA Region. [ http://www.searo.who.int/EN/ Section10/Section21/Section340-4018.htm ]
2. Progress in malaria control in China. Tang LH, Chin Med J 2000 115 69 92
3. China action plan for malaria elimination http://www.moh.gov.cn/ publicfiles/business/htmlfiles/mohjbyfkzj/s3593/201005/47529.htm
4. Malaria situation in the Peoples Republic of China in 2008. Zhou SS, Wang Y, Fang W, Tang LH, Chin J Parasitol Parasit Dis 2009 27 455 457
5. Malaria situation in the Peoples Republic of China in 2010. Zhou SS, Wang Y, Li Y, Chin J Parasitol Parasit Dis 2011 29 401 403
6. Malaria Surveillance Project in China Ministry of Health, Beijing 2005
7. Alteration in resistance of Plasmodium falciparum to chloroquine after cessation of chloroquine medication for twelve years. Liu DQ, Liu RJ, Ren DX, Gao DQ, Zhang CY, Qiu CP, Cai XZ, Ling CF, Liang AH, Tang Y, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1992 10 241 244 1303327
8. Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China. Liu DQ, Liu RJ, Ren DX, Gao DQ, Zhang CY, Qiu CP, Cai XZ, Ling CF, Liang AH, Tang Y, Bull World Health Organ 1995 73 483 486 7554020
9. Fluctuation in the Resistance of Plasmodium falciparum to chloroquine in China. Liu DQ, Feng XP, Yangh HL, Lin SG, Chen WJ, Yang PF, Chin J Parasitol Parasit Dis 2005 23 27 31
10. WHO, Guidelines for the treatment of malaria World Health Organization, Geneva 2010
11. Antimalarial drug policy in China http://www.moh.gov.cn/publicfiles/ business/htmlfiles/mohjbyfkzj/s3594/200907/41610.htm
12. History, dynamics, and public health importance of malaria parasite resistance. Talisuna AO, Bloland P, DAlessandro U, Clin Microbiol Rev 2004 17 235 254 10.1128/CMR.17.1.235-254.2004 14726463
13. WHO, Methods for surveillance of antimalarial drug efficacy World Health Organization, Geneva 2009
14. A molecular marker for chloroquine-resistant falciparum malaria. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152
15. Plasmodium falciparum genotypes associated with chloroquine and amodiaquine resistance in Guinea-Bissau. Ursing J, Kofoed PE, Rodrigues A, Rombo L, Gil JP, Am J Trop Med Hyg 2007 76 844 848 17488902
16. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P, Malar J 2009 8 89 10.1186/1475-2875-8-89 19413906
17. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D, J Infect Dis 2001 183 1535 1538 10.1086/320195 11319692
18. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil. Basco LK, Ringwald P, Am J Trop Med Hyg 2000 62 271 276 10813484
19. Drug-resistant malaria-an insight. Hyde JE, FEBS J 2007 274 4688 4698 10.1111/j.1742-4658.2007.05999.x 17824955
20. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV, J Infect Dis 2002 185 380 388 10.1086/338566 11807721
21. Emergence of a dhfr mutation conferring high level drug resistance in Plasmodium falciparum populations from southwest Uganda. Lynch C, Pearce R, Pota H, Cox J, Abeku TA, Rwakimari J, Naidoo I, Tibenderana J, Roper C, J Infect Dis 2008 197 1598 1604 10.1086/587845 18471065
22. Artemisinins target the SERCA of Plasmodium falciparum. Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, O'Neill PM, Bray PG, Ward SA, Krishna S, Nature 2003 424 957 961 10.1038/nature01813 12931192
23. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Uhlemann AC, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, Zuniga FA, East M, Lee A, Brady L, Haynes RK, Krishna S, Nat Struct Mol Biol 2005 12 628 9 10.1038/nsmb947 15937493
24. Resistance ofPlasmodium falciparumfield isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalon OS, Lancet 2005 366 1960 1963 10.1016/S0140-6736(05)67787-2 16325698
25. Molecular analysis of chloroquine resistance in Plasmodium falciparum in Yunnan Province China. Yang Z, Zhang Z, Sun X, Wan W, Cui L, Trop Med Int Health 2007 12 1051 60 10.1111/j.1365-3156.2007.01882.x 17875016
26. Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in China. Zhang GQ, Guan YY, Zheng B, Wu S, Tang LH, Trop Med Int Health 2009 14 1266 71 10.1111/j.1365-3156.2009.02342.x 19772548
27. WHO, Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations World Health Organization, Geneva 2008 http://www.who.int/malaria/resistance
28. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naudé B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE, Mol Cell 2000 6 861 871 10.1016/S1097-2765(05)00077-8 11090624
29. A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance. Lakshmanan V, Bray PG, Verdier-Pinard D, Johnson DJ, Horrocks P, Muhle RA, Alakpa GE, Hughes RH, Ward SA, Krogstad DJ, Sidhu AB, Fidock DA, EMBO J 2005 24 2294 2305 10.1038/sj.emboj.7600681 15944738
30. Efficiency of pyrimethamine salt for P. vivax prophylaxis. Wang RZ, Railway Medicine 1981 4 246 247
31. Longitudinal surveillance of chloroquine resistance of Plasmodium falciparum after cessation of medication in south Yunnan. Yang HL, Yang PF, Dong Y, Che LG, Chen WC, He H, Liu DQ, Liu RJ, Zhan B, Zhang CY, Gao DQ, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1994 12 31 33 8044901
32. Variations in the sequence and expression of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) and their relationship to chloroquine resistance in vitro. Durrand V, Berry A, Sem R, Glaziou P, Beaudou J, Fandeur T, Mol Biochem Parasitol 2004 136 273 85 10.1016/j.molbiopara.2004.03.016 15478806
33. Molecular epidemiology of drug resistance markers of Plasmodium falciparum malaria in Thailand. Congpuong K, Na Bangchang K, Mungthin M, Bualombai P, Wernsdorfer WH, Trop Med Int Health 2005 10 717 722 10.1111/j.1365-3156.2005.01450.x 16045457
34. The point mutations in Pfcrt and Pfmdr1 genes in Plasmodium falciparum isolated from Hainan Province. Guan YY, Tang LH, Hu L, Feng XP, Liu DQ, Chin J Parasitol Parasit Dis 2005 23 135 139
35. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC, Mol Biochem Parasitol 2000 108 13 23 10.1016/S0166-6851(00)00201-2 10802315
36. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Foote SJ, Kyle DE, Martin RK, Oduola AM, Forsyth K, Kemp DJ, Cowman AF, Nature 1990 345 255 25 10.1038/345255a0 2185424
37. Chloroquine susceptibility and reversibility in a Plasmodium falciparum genetic cross. Patel JJ, Thacker D, Tan JC, Pleeter P, Checkley L, Gonzales JM, Deng B, Roepe PD, Cooper RA, Ferdig MT, Mol Microbiol 2010 78 770 787 10.1111/j.1365-2958.2010.07366.x 20807203
38. Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Sá JM, Twu O, Hayton K, Reyes S, Fay MP, Ringwald P, Wellems TE, Proc Natl Acad Sci USA 2009 106 18883 18889 10.1073/pnas.0911317106 19884511
39. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S, Lancet 2004 364 438 447 10.1016/S0140-6736(04)16767-6 15288742
40. Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance. Veiga MI, Ferreira PE, Jörnhagen L, Malmberg M, Kone A, Schmidt BA, Petzold M, Björkman A, Nosten F, Gil JP, PLoS One 2011 6 20212 10.1371/journal.pone.0020212
41. Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia. Khim N, Bouchier C, Ekala MT, Incardona S, Lim P, Legrand E, Jambou R, Doung S, Puijalon OM, Fandeur T, Antimicrob Agents Chemother 2005 49 3147 3152 10.1128/AAC.49.8.3147-3152.2005 16048916
42. Geographical distribution of selected and putatively neutral SNPs in Southeast Asian malaria parasites. Anderson TJ, Nair S, Sudimack D, Williams JT, Mayxay M, Newton PN, Guthmann JP, Smithuis FM, Tran TH, van den Broek IV, White NJ, Nosten F, Mol Biol Evol 2005 22 2362 2374 10.1093/molbev/msi235 16093566
43. Artemisinin resistance: how can we find it? Noedl H, Trends Parasitol 2005 21 404 405 10.1016/j.pt.2005.06.012 16046187
44. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
45. Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
46. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Noedl H, Se Y, Sriwichai S, Schaecher K, Teja-Isavadharm P, Smith B, Rutvisuttinunt W, Bethell D, Surasri S, Fukuda MM, Socheat D, Chan Thap L, Clin Infect Dis 2010 51 82 89 10.1086/657120
47. Diversity of the sarco/endoplasmic reticulum Ca(2+)-ATPase orthologue of Plasmodium falciparum (PfATP6). Dahlström S, Veiga MI, Ferreira P, Mårtensson A, Kaneko A, Andersson B, Björkman A, Gil JP, Infect Genet Evol 2008 8 340 345 10.1016/j.meegid.2008.02.002 18359278
48. New PfATP6 mutations found in Plasmodium falciparum isolates from Vietnam. Bertaux L, le Quang H, Sinou V, Thanh NX, Parzy D, Antimicrob Agents Chemother 2009 53 4570 4571 10.1128/AAC.00684-09 19687249
49. Diversity of the sarco/endoplasmic reticulum Ca2+-ATPase orthologue of Plasmodium falciparum (PfATP6). Dahlström S, Veiga MI, Ferreira P, Mårtensson A, Kaneko A, Andersson B, Björkman A, Gil JP, Infect Genet Evol 2008 8 340 345 10.1016/j.meegid.2008.02.002 18359278
50. Polymorphism of PfATPase in Niger: detection of three new point mutations. Ibrahim ML, Khim N, Adam HH, Ariey F, Duchemin JB, Malar J 2009 8 28 10.1186/1475-2875-8-28 19226462
51. Detection of novel point mutations in the Plasmodium falciparum ATPase6 candidate gene for resistance to artemisinins. Menegon M, Sannella AR, Majori G, Severini C, Parasitol Int 2008 57 233 235 10.1016/j.parint.2007.12.004 18187359
52. Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. Imwong M, Dondorp AM, Nosten F, Yi P, Mungthin M, Hanchana S, Das D, Phyo AP, Lwin KM, Pukrittayakamee S, Lee SJ, Saisung S, Koecharoen K, Nguon C, Day NP, Socheat D, White NJ, Antimicrob Agents Chemother 2010 54 2886 2892 10.1128/AAC.00032-10 20421395